Information Journal Paper
APA:
Copy. (2017). Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study. BIOMEDICINE & PHARMACOTHERAPY, 94(-), 150-164. SID. https://sid.ir/paper/661633/en
Vancouver:
Copy. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study. BIOMEDICINE & PHARMACOTHERAPY[Internet]. 2017;94(-):150-164. Available from: https://sid.ir/paper/661633/en
IEEE:
Copy, “Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study,” BIOMEDICINE & PHARMACOTHERAPY, vol. 94, no. -, pp. 150–164, 2017, [Online]. Available: https://sid.ir/paper/661633/en